Literature DB >> 10088812

Tonic ocular tilt reaction simulating a superior oblique palsy: diagnostic confusion with the 3-step test.

S P Donahue1, P J Lavin, L M Hamed.   

Abstract

BACKGROUND: The tonic ocular tilt reaction (OTR) consists of vertical divergence of the eyes (skew deviation), bilateral conjugate ocular torsion, and paradoxical head tilt. The head and superior pole of both eyes are rotated toward the hypotropic eye.
OBJECTIVE: To describe ocular motility and torsion findings in 5 patients with OTRs that mimicked superior oblique palsies (SOPs).
RESULTS: In 5 patients, results of the 3-step test suggested an SOP (bilateral in 1 patient); however, no patient had the expected excyclotorsion of the hypertropic eye. Two patients had conjugate ocular torsion (intorsion of the hypertropic eye and extorsion of the hypotropic eye), and 2 patients had only intorsion of the hypertropic eye. All had other neurologic features consistent with more widespread brainstem disease.
CONCLUSIONS: Vertical ocular deviations that 3-step to an SOP are not always caused by fourth nerve weakness. When a patient with an apparent fourth nerve palsy has ocular torsion that is inconsistent with an SOP, OTR should be suspected, especially if vestibular system or posterior fossa dysfunction coexists. The rules for the 3-step test for an SOP may be fulfilled by damaging the otolithic projections corresponding to projections of the contralateral anterior semicircular canal. Because results of the Bielschowsky head tilt test may be positive in patients with the OTR, the feature distinguishing OTR from an SOP is the direction of torsion. We advocate use of a fourth step-evaluation of ocular torsion-in addition to the standard 3 steps.

Entities:  

Mesh:

Year:  1999        PMID: 10088812     DOI: 10.1001/archopht.117.3.347

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  11 in total

1.  Gillies Lecture: ocular motility in a time of paradigm shift.

Authors:  Joseph L Demer
Journal:  Clin Exp Ophthalmol       Date:  2006-12       Impact factor: 4.207

Review 2.  Mechanics of the orbita.

Authors:  Joseph L Demer
Journal:  Dev Ophthalmol       Date:  2007

3.  Functional imaging of human extraocular muscles in head tilt dependent hypertropia.

Authors:  Joseph L Demer; Jennifer Kung; Robert A Clark
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-09       Impact factor: 4.799

4.  Vertical vergence adaptation produces an objective vertical deviation that changes with head tilt.

Authors:  Kristina Irsch; David L Guyton; Nicholas A Ramey; Rohit S Adyanthaya; Howard S Ying
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-05-03       Impact factor: 4.799

5.  The Value and Caveats of Interpreting Small Case Series: Implications for Patient Care.

Authors:  Richard K Parrish; Ta Chen Chang; Sarah L Duncan Powers
Journal:  Am J Ophthalmol       Date:  2019-11-05       Impact factor: 5.258

6.  Rectus Pulley Displacements without Abnormal Oblique Contractility Explain Strabismus in Superior Oblique Palsy.

Authors:  Soh Youn Suh; Alan Le; Robert A Clark; Joseph L Demer
Journal:  Ophthalmology       Date:  2016-03-13       Impact factor: 12.079

Review 7.  Understanding skew deviation and a new clinical test to differentiate it from trochlear nerve palsy.

Authors:  Agnes M F Wong
Journal:  J AAPOS       Date:  2010-02       Impact factor: 1.220

8.  Torsional augmentation for the treatment of lateropulsion and torticollis in partial ocular tilt reaction.

Authors:  Michael C Brodsky; Jonathan M Holmes
Journal:  J AAPOS       Date:  2012-04       Impact factor: 1.220

9.  Effects of intracranial trochlear neurectomy on the structure of the primate superior oblique muscle.

Authors:  Joseph L Demer; Vadims Poukens; Howard Ying; Xiaoyan Shan; Jing Tian; David S Zee
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-02-17       Impact factor: 4.799

10.  Differentiating Acute and Subacute Vertical Strabismus Using Different Head Positions During the Upright-Supine Test.

Authors:  João Lemos; Adnan Subei; Mário Sousa; César Nunes; Luís Cunha; Christopher Glisson; Eric Eggenberger
Journal:  JAMA Ophthalmol       Date:  2018-04-01       Impact factor: 7.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.